These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 22749710

  • 1. Identifying patients at risk of late recovery (≥ 8 days) from acute exacerbation of chronic bronchitis and COPD.
    Anzueto A, Miravitlles M, Ewig S, Legnani D, Heldner S, Stauch K.
    Respir Med; 2012 Sep; 106(9):1258-67. PubMed ID: 22749710
    [Abstract] [Full Text] [Related]

  • 2. Characterisation of exacerbations of chronic bronchitis and COPD in Europe: the GIANT study.
    Miravitlles M, Anzueto A, Ewig S, Legnani D, Stauch K.
    Ther Adv Respir Dis; 2009 Dec; 3(6):267-77. PubMed ID: 19880426
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of moxifloxacin in acute exacerbations of chronic bronchitis: a prospective, multicenter, observational study (AVANTI).
    Chuchalin A, Zakharova M, Dokic D, Tokić M, Marschall HP, Petri T.
    BMC Pulm Med; 2013 Jan 23; 13():5. PubMed ID: 23343427
    [Abstract] [Full Text] [Related]

  • 5. Antibiotic treatment and factors influencing short and long term outcomes of acute exacerbations of chronic bronchitis.
    Wilson R, Jones P, Schaberg T, Arvis P, Duprat-Lomon I, Sagnier PP, MOSAIC Study Group.
    Thorax; 2006 Apr 23; 61(4):337-42. PubMed ID: 16449273
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis.
    Zervos M, Martinez FJ, Amsden GW, Rothermel CD, Treadway G.
    Int J Antimicrob Agents; 2007 Jan 23; 29(1):56-61. PubMed ID: 17189096
    [Abstract] [Full Text] [Related]

  • 7. Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis.
    Wilson R, Allegra L, Huchon G, Izquierdo JL, Jones P, Schaberg T, Sagnier PP, MOSAIC Study Group.
    Chest; 2004 Mar 23; 125(3):953-64. PubMed ID: 15006954
    [Abstract] [Full Text] [Related]

  • 8. Double-blind study of OM-85 in patients with chronic bronchitis or mild chronic obstructive pulmonary disease.
    Solèr M, Mütterlein R, Cozma G, Swiss-German OM-85 Study Group.
    Respiration; 2007 Mar 23; 74(1):26-32. PubMed ID: 16772707
    [Abstract] [Full Text] [Related]

  • 9. Prulifloxacin versus levofloxacin in the treatment of severe COPD patients with acute exacerbations of chronic bronchitis.
    Blasi F, Schaberg T, Centanni S, Del Vecchio A, Rosignoli MT, Dionisio P.
    Pulm Pharmacol Ther; 2013 Oct 23; 26(5):609-16. PubMed ID: 23538168
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD.
    Miravitlles M.
    Int J Chron Obstruct Pulmon Dis; 2007 Oct 23; 2(3):191-204. PubMed ID: 18229559
    [Abstract] [Full Text] [Related]

  • 15. Moxifloxacin versus levofloxacin against acute exacerbations of chronic bronchitis: the Latin American Cohort.
    Urueta-Robledo J, Ariza H, Jardim JR, Caballero A, García-Calderón A, Amábile-Cuevas CF, Hernández-Oliva G, Vivar-Orozco R, MOX-CB Study Group.
    Respir Med; 2006 Sep 23; 100(9):1504-11. PubMed ID: 16504492
    [Abstract] [Full Text] [Related]

  • 16. Real-life treatment of acute exacerbations of chronic bronchitis with moxifloxacin or macrolides: a comparative post-marketing surveillance study in general practice.
    Schaberg T, Möller M, File T, Stauch K, Landen H.
    Clin Drug Investig; 2006 Sep 23; 26(12):733-44. PubMed ID: 17274680
    [Abstract] [Full Text] [Related]

  • 17. Short-course antibiotic treatment in acute exacerbations of chronic bronchitis and COPD: a meta-analysis of double-blind studies.
    El Moussaoui R, Roede BM, Speelman P, Bresser P, Prins JM, Bossuyt PM.
    Thorax; 2008 May 23; 63(5):415-22. PubMed ID: 18234905
    [Abstract] [Full Text] [Related]

  • 18. Frequent hospital readmissions for acute exacerbation of COPD and their associated factors.
    Cao Z, Ong KC, Eng P, Tan WC, Ng TP.
    Respirology; 2006 Mar 23; 11(2):188-95. PubMed ID: 16548905
    [Abstract] [Full Text] [Related]

  • 19. Chronic bronchitis in COPD patients is associated with increased risk of exacerbations: a cross-sectional multicentre study.
    Corhay JL, Vincken W, Schlesser M, Bossuyt P, Imschoot J.
    Int J Clin Pract; 2013 Dec 23; 67(12):1294-301. PubMed ID: 24246208
    [Abstract] [Full Text] [Related]

  • 20. A novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodology.
    Wilson R, Anzueto A, Miravitlles M, Arvis P, Faragó G, Haverstock D, Trajanovic M, Sethi S.
    Int J Chron Obstruct Pulmon Dis; 2011 Dec 23; 6():373-83. PubMed ID: 21760724
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.